Natco Pharma

  • Market Cap: Small Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: INE987B01026
  • NSEID: NATCOPHARM
  • BSEID: 524816
INR
1,016.75
-158.85 (-13.51%)
BSENSE

May 29

BSE+NSE Vol: 41.28 lacs

  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationQuarterly Results
Results Snapshot
YoYQoQ
Figures in Cr
Consolidate Quarterly Results
Mar'26
Dec'25
Sep'25
Jun'25
Mar'25
Dec'24
Sep'24
Net Sales
739.10
647.30
1,363.00
1,328.90
1,221.00
474.80
1,371.10
Other Operating Income
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Total Operating income
739.10
647.30
1,363.00
1,328.90
1,221.00
474.80
1,371.10
Raw Material Cost
102.80
135.20
174.90
180.60
169.00
72.70
143.20
Purchase of Finished goods
37.50
55.80
72.60
37.30
40.80
39.10
53.70
(Increase) / Decrease In Stocks
14.40
-57.90
-77.80
15.10
39.40
-29.00
-19.30
Employee Cost
158.50
159.40
200.30
169.00
159.40
141.60
151.50
Power Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Manufacturing Expenses
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Selling and Distribution Expenses
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other Expenses
298.30
196.10
413.80
355.90
264.30
211.60
237.70
Total Expenditure (Excl Depreciation)
611.50
488.60
783.80
757.90
672.90
436.00
566.80
Operating Profit (PBDIT) excl Other Income
127.60
158.70
579.20
571.00
548.10
38.80
804.30
Other Income
77.80
58.10
100.00
61.70
66.30
176.30
63.80
Operating Profit (PBDIT)
205.40
216.80
679.20
632.70
614.40
215.10
868.10
Interest
10.90
9.50
13.10
3.20
10.20
4.40
4.10
Exceptional Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Gross Profit (PBDT)
194.50
207.30
666.10
629.50
604.20
210.70
864.00
Depreciation
50.40
46.20
52.40
57.60
98.30
47.00
45.80
Profit Before Tax
144.10
161.10
613.70
571.90
505.90
163.70
818.20
Tax
-89.20
20.70
95.80
91.60
99.90
31.30
141.70
Provisions and contingencies
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Profit After Tax
233.30
140.40
517.90
480.30
406.00
132.40
676.50
Extraordinary Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Net Profit
233.30
140.40
517.90
480.30
406.00
132.40
676.50
Share in Profit of Associates
35.70
10.90
0.00
0.00
0.00
0.00
0.00
Minority Interest
1.10
-0.20
-0.50
-0.40
-0.60
-0.60
-0.80
Other related items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Consolidated Net Profit
267.90
151.50
518.40
480.70
406.60
133.00
677.30
Equity Capital
35.80
35.80
35.80
35.80
35.80
35.80
35.80
Face Value
2.0
2.0
2.0
2.0
2.0
2.0
2.0
Reserves
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Earnings per share (EPS)
14.97
8.46
28.96
26.85
22.72
7.43
37.84
Diluted Earnings per share
14.96
8.46
28.94
26.84
22.7
7.43
37.81
Operating Profit Margin (Excl OI)
17.26%
24.52%
42.49%
42.97%
44.89%
8.17%
58.66%
Gross Profit Margin
26.32%
32.03%
48.87%
47.37%
49.48%
44.38%
63.02%
PAT Margin
31.57%
21.69%
38.0%
36.14%
33.25%
27.89%
49.34%
Public Share Holdings (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Pledged Promotor Holding (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Quarterly Analysis Highlights - QoQ
stock-summary

Net Sales

QoQ Growth in quarter ended Mar 2026 is 14.18% vs -52.51% in Dec 2025

stock-summary

Consolidate Net Profit

QoQ Growth in quarter ended Mar 2026 is 76.83% vs -70.78% in Dec 2025

stock-summary

Operating Profit (PBDIT) excl Other Income

QoQ Growth in quarter ended Mar 2026 is -19.60% vs -72.60% in Dec 2025

stock-summary

Interest

QoQ Growth in quarter ended Mar 2026 is 14.74% vs -27.48% in Dec 2025

stock-summary

Operating Profit Margin (Excl OI)

QoQ Growth in quarter ended Mar 2026 has fallen from Dec 2025

Compare Quarterly Results Of Natco Pharma With
Markets Mojo
Figures in Cr
Consolidate Quarterly Results
Markets Mojo
Markets Mojo
Change(INR)
Change(%)
Net Sales
739.10
0
739.10
Other Operating Income
0.00
0.00
0.00
Total Operating income
739.10
0
739.10
Raw Material Cost
102.80
0
102.80
Purchase of Finished goods
37.50
0
37.50
(Increase) / Decrease In Stocks
14.40
0
14.40
Employee Cost
158.50
0
158.50
Power Cost
0.00
0
0.00
Manufacturing Expenses
0.00
0
0.00
Selling and Distribution Expenses
0.00
0
0.00
Other Expenses
298.30
0.00
298.30
Total Expenditure (Excl Depreciation)
611.50
0
611.50
Operating Profit (PBDIT) excl Other Income
127.60
0.00
127.60
Other Income
77.80
0
77.80
Operating Profit (PBDIT)
205.40
0
205.40
Interest
10.90
0
10.90
Exceptional Items
0.00
0
0.00
Gross Profit (PBDT)
194.50
0
194.50
Depreciation
50.40
0
50.40
Profit Before Tax
144.10
0
144.10
Tax
-89.20
0
-89.20
Provisions and contingencies
0.00
0
0.00
Profit After Tax
233.30
0
233.30
Extraordinary Items
0.00
0
0.00
Prior Period Expenses
0.00
0
0.00
Other Adjustments
0.00
0
0.00
Net Profit
233.30
0
233.30
Share in Profit of Associates
35.70
0
35.70
Minority Interest
1.10
0
1.10
Other related items
0.00
0.00
0.00
Consolidated Net Profit
267.90
0
267.90
Equity Capital
35.80
0
35.80
Face Value
2.00
0
0.00
Reserves
0.00
0
0.00
Earnings per share (EPS)
14.97
0
14.97
Diluted Earnings per share
14.96
0
14.96
Operating Profit Margin (Excl OI)
17.26%
0%
0.00
17.26%
Gross Profit Margin
26.32%
0%
0.00
26.32%
PAT Margin
31.57%
0%
0.00
31.57%
Public Share Holdings (%)
0.00%
0%
0.00
0.00%
Pledged Promotor Holding (%)
0.00%
0%
0.00
0.00%
Quarterly - Net Sales
Net Sales 739.10 Cr
in Mar 2026

Figures in Cr
stock-summary

QoQ Growth in quarter ended Mar 2026 is 14.18% vs -52.51% in Dec 2025

stock-summary

YoY Growth in quarter ended Mar 2026 is -39.47% vs 14.29% in Mar 2025

Quarterly - Consolidate Net Profit
Consolidate Net Profit 267.90 Cr
in Mar 2026

Figures in Cr
stock-summary

QoQ Growth in quarter ended Mar 2026 is 76.83% vs -70.78% in Dec 2025

stock-summary

YoY Growth in quarter ended Mar 2026 is -34.11% vs 5.25% in Mar 2025

Quarterly - Operating Profit (PBDIT)
Operating Profit (PBDIT) 127.60 Cr
in Mar 2026

Figures in Cr
stock-summary

QoQ Growth in quarter ended Mar 2026 is -19.60% vs -72.60% in Dec 2025

stock-summary

YoY Growth in quarter ended Mar 2026 is -76.72% vs 10.22% in Mar 2025

Quarterly - Interest
Interest 10.90 Cr
in Mar 2026

Figures in Cr
stock-summary

QoQ Growth in quarter ended Mar 2026 is 14.74% vs -27.48% in Dec 2025

stock-summary

YoY Growth in quarter ended Mar 2026 is 6.86% vs 64.52% in Mar 2025

Quarterly - Operating Profit Margin (Excl OI)
Operating Profit Margin (Excl OI) 17.26%
in Mar 2026

Figures in %
stock-summary

QoQ Growth in quarter ended Mar 2026 has fallen from Dec 2025

stock-summary

YoY Growth in quarter ended Mar 2026 has fallen from Mar 2025